For sales

Highlights from the Week of 29th June – 06th July world of pharma and healthcare!

Highlights from the Week of 29th June 2026 - 06th July 2026 ( FDA, Approval ) FDA approves Vertex's CASGEVY for expanded use to treat people aged 2 years and older with either SCD with recurrent VOCs or transfusion-dependent beta thalassemia ( FDA, Approval ) Orca Bio gets FDA approval of ORCA-T for use in chronic GVHD-free survival in the treatment of adults with hematological malignancies ( EU, Approval ) EC approves Novartis' ITVISMA for the treatment of children aged two years and older, teens and adults with 5q SMA with a bi-allelic mutation in the SMN gene ( FDA, Priority Review ) FDA provides priority review to Roche’s sBLA for ENSPRYNG as a subcutaneous therapy for the treatment of TED Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.